An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 276 - 300 of 704

  1. Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus receptor binding

    • Allergy
      • Viruses
      • COVID-19
  2. Delayed virus‐specific antibody responses associate with COVID‐19 mortality

    • Allergy
      • Viruses
      • COVID-19
  3. Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19

    • Allergy
    • Large differences in COVID‐19 death rates exist between countries and between regions of the same country. Some very low death rate countries such as Eastern Asia, Central Europe or the Balkans have a common feature of eating large quantities of fermented foods. Although biases exist when examining ecological studies, fermented vegetables or cabbage were associated with low death rates in European countries. SARS‐CoV‐2 binds to its receptor, the angiotensin converting enzyme 2 (ACE2).

      • Viruses
      • COVID-19
  4. Dupilumab, Severe Asthma Airway Responses, and SARS‐CoV2 Serology

    • Allergy
    • There is paucity of evidence assessing immune responses to COVID‐19 in severe asthmatics treated with biologics. Recent guidelines recommend continuing these agents (as clinically indicated) to maintaining asthma control.

      • Viruses
      • COVID-19
  5. COVID‐19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey

    • Allergy
      • Viruses
      • COVID-19
  6. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID‐19

    • Allergy
    • After adjusting for confounding factors, COVID‐19 patients with COPD have higher risks of developing severe illness and acute respiratory distress syndrome than COVID‐19 patients with asthma. COPD patients have increased, whereas asthmatics have decreased ACE2 protein expression in lower airways, compared with that in control subjects without asthma and COPD. IL‐17A, TNF‐α, and IL‐12 promote, while IL‐4 and IL‐13 suppress ACE2 expression in airway BEAS‐2B cells.

      • Viruses
      • COVID-19
  7. SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?

    • Allergy
    • The pandemic condition coronavirus disease (COVID‐19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can take asymptomatic, mild, moderate, and severe courses. COVID‐19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatigue, and diarrhea and can end up in interstitial pneumonia and severe respiratory failure.

      • Viruses
      • COVID-19
  8. “Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry”

    • Allergy
      • Viruses
      • COVID-19
  9. Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issue

    • Allergy
      • Viruses
      • COVID-19
  10. Atopic statusprotects from severe complications of COVID‐19

    • Allergy
      • Viruses
      • COVID-19
  11. COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

    • Allergy
      • Viruses
      • COVID-19
  12. Comparative in silico design and validation of GPS™ CoVID‐19 dtec‐RT‐qPCR test

    • Journal of Applied Microbiology
    • Aims Providing a ready‐to‐use reverse transcriptase qPCR (RT‐qPCR) method fully validated to detect the SARS‐CoV‐2 with a higher exclusivity than this shown by early published RT‐qPCR designs. Methods and Results The specificity of the GPS™ CoVID‐19 dtec‐RT‐qPCR test by analysis of sequence alignments was approached and compared with other RT‐qPCR designs. The GPS™ CoVID‐19 dtec‐RT‐qPCR test was validated following criteria of UNE/EN ISO 17025:2005 and ISO/IEC 15189:2012.

      • Viruses
      • COVID-19
  13. Antiviral activities of mycophenolic acid and IMD‐0354 against SARS‐CoV‐2

    • Microbiology and Immunology
    • In this study, the anti–severe acute respiratory syndrome coronavirus‐2 (anti‐SARS‐CoV‐2) activity of mycophenolic acid (MPA) and IMD‐0354 was analyzed. These compounds were chosen based on their antiviral activities against other coronaviruses. Because they also inhibit dengue virus (DENV) infection, other anti‐DENV compounds/drugs were also assessed.

      • Viruses
      • COVID-19
  14. The SARS‐CoV‐2/COVID‐19 pandemic and challenges in stroke care in India

    • Annals of the New York Academy of Sciences
    • We outline the unfavorable circumstances in stroke care induced by the SARS‐CoV‐2/COVID‐19 pandemic, propose mitigating measures, crisis management, and provide a comparative evaluation of stroke care between India and United States during the pandemic. Abstract Stroke care in India has evolved rapidly in the last decade with a focus on stroke awareness, prevention, rapid triage, treatment, and rehabilitation.

      • Viruses
      • COVID-19
  15. The Persisting Importance of Rhetoric and Equity in Health Policy and Outcomes

    • World Medical & Health Policy
    • This editorial considers the persisting importance of rhetoric and equity in health policy analysis, implementation, and outcomes. It argues that employing social determinants of health, and intersectional and rhetorical frames, can improve life and health outcomes, as measured by morbidity and mortality. The pertinence of these frames with regard to the crises brought on by the COVID‐19 pandemic is discussed, and the plan for a special issue on disparties and COVID‐19 is announced.

      • Viruses
      • COVID-19
  16. Illicit Wildlife Trade, Wet Markets, and COVID‐19: Preventing Future Pandemics

    • World Medical & Health Policy
    • Although the exact origin of SARS‐CoV‐2, the etiologic agent of COVID‐19, is currently unknown, there is substantial evidence to suggest the source of transmission of the virus occurred within the Wuhan wet market. In these markets, bats and wild animals are frequently sold and stored in close contact. During several of the world's past pandemics, bats were essential to the spread of zoonotic diseases from bat to another animal or to humans directly.

      • Viruses
      • COVID-19
  17. Beyond the Pathogen: Social and Behavioral Aspects of COVID‐19

    • World Medical & Health Policy
    • COVID‐19 presents an existential challenge for millions of people and a generational challenge for the globe. Scientific research is the primary vehicle in humanity's attempts to understand the virus and mitigate its effects. Research on the pathogen is critically important. At the same time, COVID‐19's consequences are due to more than the pathogen.

      • Viruses
      • COVID-19
  18. Preventing COVID‐19 Amid Public Health and Urban Planning Failures in Slums of Indian Cities

    • World Medical & Health Policy
    • The COVID‐19 pandemic has brought renewed attention to the lack of urban planning and its public health implications in developing countries. Slum communities face the dual challenges of chronically poor residential environments and the acute effects of a pandemic and the preventive measures that follow.

      • Viruses
      • COVID-19
  19. Strategies for Effective Health Communication during the Coronavirus Pandemic and Future Emerging Infectious Disease Events

    • World Medical & Health Policy
    • An emerging infectious disease event like the coronavirus (COVID‐19) pandemic demands careful communication of public health messages to diverse audiences. However, misinformation is easily generated and amplified when a rapidly evolving epidemiological situation is coupled with gaps in scientific knowledge about a novel pathogen.

      • Viruses
      • COVID-19
  20. Epidemics and Pandemics: Coronavirus Disease in the United States, Lessons Learned and Way Forward

    • World Medical & Health Policy
    • In spite of presumed readiness to confront infectious disease outbreaks, the United States was unprepared for the advent of the novel Coronavirus disease (COVID‐19) in the early months of 2020. The response was slow, mired in ad hoc responses, lack of planning, challenges in supply chains and human resources, and discord in balancing public health measures with economic considerations arising from far‐reaching disruptions in various sectors. The lessons learned derive from such challenges.

      • Viruses
      • COVID-19
  21. Statewide COVID‐19 Stay‐at‐Home Orders and Population Mobility in the United States

    • World Medical & Health Policy
    • Many jurisdictions enacted stay‐at‐home orders (also called shelter‐in‐place orders, safer‐at‐home orders, or lockdowns) when SARS‐CoV‐2 began spreading in the United States. Based on Google mobility data, every state had substantially fewer visits to transit stations, retail and recreation facilities, workplaces, grocery stores, and pharmacies by the end of March 2020 than in the previous two months.

      • Viruses
      • COVID-19
  22. Fentanyl, COVID‐19, and Public Health

    • World Medical & Health Policy
    • COVID‐19 temporarily severed the production and the supply chains for fentanyl, a synthetic narcotic responsible for over 30,000 deaths in the United States in 2018. Much fentanyl was produced in Wuhan, China, the source of the epidemic. Fentanyl was previously sold directly to American consumers through online websites and was also supplied by Mexican drug traffickers, who produced the drug from precursor chemicals purchased from China.

      • Viruses
      • COVID-19
  23. Racial Disparities in COVID‐19 Mortality Among Essential Workers in the United States

    • World Medical & Health Policy
    • Racial disparities are apparent in the impact of coronavirus disease 2019 (COVID‐19) in the United States, yet the factors contributing to racial inequities in COVID‐19 mortality remain controversial. To better understand these factors, we investigated racial disparities in COVID‐19 mortality among America's essential workers.

      • Viruses
      • COVID-19
  24. Partnering Small Enterprises and Local Nonprofits to Help Sustain Local Economies and Reduce the Spread of COVID‐19

    • World Medical & Health Policy
    • A lesson learned from decades of research is that businesses and nonprofits can form private partnerships to serve the public good. One such partnership is a cause‐related marketing campaign, where a business donates a portion of its sales to a nonprofit to address a social need.

      • Viruses
      • COVID-19
  25. Coronavirus, Refugees, and Government Policy: The State of U.S. Refugee Resettlement during the Coronavirus Pandemic

    • World Medical & Health Policy
    • The novel coronavirus pandemic poses unique challenges to forcibly displaced populations around the world. Months into the pandemic, countries are still scrambling to enact policies that mitigate the outbreak and minimize the strain on their health‐care infrastructures and economies. The United Nations High Commissioner for Refugees continues to work with member states to provide guidance and assistance to those populations protected under their mandate.

      • Viruses
      • COVID-19